Spyre Therapeutics, Inc.

DB:3920 Stock Report

Market Cap: €1.6b

Spyre Therapeutics, Inc. Company Information

Spyre Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Spyre Therapeutics, Inc.
  • Ticker: 3920
  • Exchange: DB
  • Founded: 2013
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.626b
  • Listing Market Cap: US$1.562b
  • Shares Outstanding: 58.71m
  • Website: https://www.spyre.com

Number of Employees

Location

  • Spyre Therapeutics, Inc.
  • 221 Crescent Street
  • Building 23
  • Waltham
  • Massachusetts
  • 02453
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SYRENasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDApr 2016
3920DB (Deutsche Boerse AG)YesCommon StockDEEURApr 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 19:36
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.